Lifeline Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2009	FY 2004	FY 2003	FY 2002
Period Ending	Dec '09 Dec 31, 2009	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Revenue	-	0.1	0.03	-
Revenue Growth (YoY)	-	240.64%	-	-
Cost of Revenue	-	0.05	0.02	-
Gross Profit	-	0.05	0.01	-
Selling, General & Admin	0.22	0.9	0.64	0.47
Research & Development	0.35	0.38	0.29	0.32
Operating Expenses	0.56	1.34	0.99	0.85
Operating Income	-0.56	-1.29	-0.98	-0.85
Interest Expense	-0.01	-	-	-
Interest & Investment Income	-	0	0	0
EBT Excluding Unusual Items	-0.57	-1.29	-0.98	-0.85
Asset Writedown	-	-0.31	-0.11	-
Pretax Income	-0.57	-1.6	-1.09	-0.85
Earnings From Continuing Operations	-0.57	-1.6	-1.09	-0.85
Earnings From Discontinued Operations	-	-0.15	0.23	-0.01
Net Income	-0.57	-1.74	-0.85	-0.86
Net Income to Common	-0.57	-1.74	-0.85	-0.86
Shares Outstanding (Basic)	2,913	-	-	-
Shares Outstanding (Diluted)	2,913	-	-	-
EPS (Basic)	-0.00	-	-	-
EPS (Diluted)	-0.00	-	-	-
Free Cash Flow	-	-1.67	-0.14	-0.88
Gross Margin	-	53.05%	34.76%	-
Operating Margin	-	-1299.52%	-3360.75%	-
Profit Margin	-	-1758.17%	-2940.45%	-
Free Cash Flow Margin	-	-1689.68%	-496.85%	-
EBITDA	-	-1.23	-0.92	-0.8
D&A For EBITDA	-	0.06	0.05	0.05
EBIT	-0.56	-1.29	-0.98	-0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.